The data containing anthropometric measures, laboratory results and medical records allowed detailed investigation of potential effects of insulin use and the residual ASCVD risks thoroughly in patients with T2DM and no prior ASCVD. This evidence concerns the gene INS and type 2 diabetes mellitus.